Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Harriette Van Spall , Stefan James Added: 10 months ago
What's hot at the ESC Congress 2024?Stay ahead of the curve with our faculty-led coverage of the European Society of Cardiology Congress in London. From groundbreaking trials to expert insights, we've got you covered.Watch ourView From the Thoraxcenterseries for practice-focused reviews of the most anticipated trials from interventional experts,Prof Nicolas Van MieghemandDr Joost Daemen.For a… View more
Author(s): Yugo Yamashita Added: 1 year ago
What's hot at the European Society of Cardiology (ESC) Congress 2023? Browse our curated coverage of the latest updates in cardiology from Amsterdam. Watch ourView From the Thoraxcenterseries for a concise line up of the most awaited trials fromProf Nicolas Van MieghemandDr Joost Daemen. For a deeper dive into key clinical trial data and its applicability, host,Dr Harriette Van… View more
Author(s): Manesh R Patel , Harriette Van Spall Added: 10 months ago
ESC Congress 2024 — OCEANIC-AF was halted early due to a lack of efficacy in 2023. Investigators shared details of the trial at ESC, comparing asundexian against apixaban in patients with atrial fibrillation at risk of stroke.Host Dr Harriette Van Spall (McMaster University, Hamilton, Canada) sits down with primary investigator Dr Manesh R Patel (Duke University Health System, USA) to discuss the… View more
Added: 12 months ago Source:  ESC Congress
The European Society of Cardiology has revealed 12 Hot-Line trial sessions to be presented at the end of August.ESC Congress 2024 will be held from the 30thAugust to the 2nd September at the ExCel Center in London. View the full programme here.Don't miss our video collection covering late-breaking data from ESC Congress 2024, including a preview of the most anticipated trials in View from the… View more
Author(s): Roland R Tilz Added: 5 months ago
AF Symposium 25 - Safety and effectiveness results show the Volt (Abbott) pulsed field ablation (PFA) system for pulmonary vein isolation (PVI) is a successful treatment option for paroxysmal and persistent atrial fibrillation patients.Prof Roland Tilz (University Heart Centre Lübeck, Lübeck, DE) joins us onsite at AF Symposium 25 to discuss the findings of balloon-based PFA for PVI. The pre… View more
Author(s): KR Julian Chun , Boris Schmidt , Richard Schilling , et al Added: 2 years ago
Following the success of Rhythm Interventions Online 2022 (30 November – 2 December 2022), here Course Co-director and operator Prof Julian Chun reviews his Single Shot Pulmonary Vein Isolation Using the Novel RF Balloon – A New Golden Era?case performed live at the event. Includes comment and insight from fellow course leadership Prof Richard Schilling (St Bartholomew's Hospital, London, UK)… View more
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 year ago
What’s hot at ACC.24?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.This preview episode of View from the Thoraxcenter offers a critical analysis of the most anticipated trials of ACC.24,… View more
Author(s): Roland R Tilz Added: 3 months ago
EHRA 2025 - Follow-up outcomes of a balloon-in-basket pulsed field ablation (PFA) system for pulmonary vein isolation (PVI) show high acute PVI isolation rates and a low adverse event rate. Overall, the balloon-in-basket PFA system proved to be a safe and feasible treatment option for PVI.Prof Roland Tilz (University Heart Centre Lübeck, Lübeck, Germany) joins us on-site at EHRA Congress 2025 to… View more